Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Dec;63(12):4781–4789. doi: 10.1128/iai.63.12.4781-4789.1995

Role of Escherichia coli P fimbriae in intestinal colonization in gnotobiotic rats.

M V Herías 1, T Midtvedt 1, L A Hanson 1, A E Wold 1
PMCID: PMC173685  PMID: 7591136

Abstract

Adherence via P fimbriae is associated with long-term persistence of Escherichia coli in the human large intestine, but a causal relationship has not been proven. In the present study, germfree rats were colonized with a mixture of two isogenic E. coli strains, one P fimbriated and the other type 1 fimbriated. Both types of fimbriae conferred adherence to rat colonic epithelial cells. With two mutant strains from a pyelonephritogenic isolate of serotype O75:K5:H-, the P-fimbriated strain 824 attained much higher numbers than its type 1-fimbriated counterpart when colonized in vivo for 2 weeks (10(10) versus 10(6) bacteria per g, respectively; P < 0.0001). The expression of P fimbriae by 824 was also retained during colonization. With transformant isogenic strains obtained from a normal fecal isolate incapable of phase variation, no benefit of P fimbriae was seen and most bacteria lost their plasmids during in vivo colonization. When the pyelonephritogenic mutant and fecal transformant strains were combined, the former colonized at high levels while the latter were suppressed. In contrast, no suppression was seen when the transformant E. coli strains colonized in combination with Lactobacillus acidophilus or Peptostreptococcus sp. The results indicate that P fimbriae, but also other bacterial traits linked to uropathogeneicity, could play an important role for persistence in the gut normal microbiota. Neither P nor type 1 fimbriae seemed to contribute to the ability to translocate to the mesenteric lymph nodes.

Full Text

The Full Text of this article is available as a PDF (1.3 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adlerberth I., Hanson L. A., Svanborg C., Svennerholm A. M., Nordgren S., Wold A. E. Adhesins of Escherichia coli associated with extra-intestinal pathogenicity confer binding to colonic epithelial cells. Microb Pathog. 1995 Jun;18(6):373–385. doi: 10.1006/mpat.1995.0034. [DOI] [PubMed] [Google Scholar]
  2. Berg R. D. Inhibition of Escherichia coli translocation from the gastrointestinal tract by normal cecal flora in gnotobiotic or antibiotic-decontaminated mice. Infect Immun. 1980 Sep;29(3):1073–1081. doi: 10.1128/iai.29.3.1073-1081.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Carlstedt-Duke B., Midtvedt T., Nord C. E., Gustafsson B. E. Isolation and characterization of a mucin-degrading strain of Peptostreptococcus from rat intestinal tract. Acta Pathol Microbiol Immunol Scand B. 1986 Oct;94(5):293–300. doi: 10.1111/j.1699-0463.1986.tb03056.x. [DOI] [PubMed] [Google Scholar]
  4. Caugant D. A., Levin B. R., Selander R. K. Genetic diversity and temporal variation in the E. coli population of a human host. Genetics. 1981 Jul;98(3):467–490. doi: 10.1093/genetics/98.3.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Edén C. S., Freter R., Hagberg L., Hull R., Hull S., Leffler H., Schoolnik G. Inhibition of experimental ascending urinary tract infection by an epithelial cell-surface receptor analogue. Nature. 1982 Aug 5;298(5874):560–562. doi: 10.1038/298560a0. [DOI] [PubMed] [Google Scholar]
  6. Eisenstein B. I. Phase variation of type 1 fimbriae in Escherichia coli is under transcriptional control. Science. 1981 Oct 16;214(4518):337–339. doi: 10.1126/science.6116279. [DOI] [PubMed] [Google Scholar]
  7. GUSTAFSSON B. E. Lightweight stainless steel systems for rearing germfree animals. Ann N Y Acad Sci. 1959 May 8;78:17–28. doi: 10.1111/j.1749-6632.1959.tb53092.x. [DOI] [PubMed] [Google Scholar]
  8. Guiot H. F. Role of competition for substrate in bacterial antagonism in the gut. Infect Immun. 1982 Dec;38(3):887–892. doi: 10.1128/iai.38.3.887-892.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gustafsson B. E., Carlstedt-Duke B. Intestinal water-soluble mucins in germfree, exgermfree and conventional animals. Acta Pathol Microbiol Immunol Scand B. 1984 Oct;92(5):247–252. doi: 10.1111/j.1699-0463.1984.tb02829.x. [DOI] [PubMed] [Google Scholar]
  10. Hagberg L., Hull R., Hull S., Falkow S., Freter R., Svanborg Edén C. Contribution of adhesion to bacterial persistence in the mouse urinary tract. Infect Immun. 1983 Apr;40(1):265–272. doi: 10.1128/iai.40.1.265-272.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hoskins L. C., Zamcheck N. Bacterial degradation of gastrointestinal mucins. I. Comparison of mucus constituents in the stools of germ-free and conventional rats. Gastroenterology. 1968 Feb;54(2):210–217. [PubMed] [Google Scholar]
  12. Korhonen T. K., Valtonen M. V., Parkkinen J., Väisänen-Rhen V., Finne J., Orskov F., Orskov I., Svenson S. B., Mäkelä P. H. Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis. Infect Immun. 1985 May;48(2):486–491. doi: 10.1128/iai.48.2.486-491.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Krogfelt K. A., McCormick B. A., Burghoff R. L., Laux D. C., Cohen P. S. Expression of Escherichia coli F-18 type 1 fimbriae in the streptomycin-treated mouse large intestine. Infect Immun. 1991 Apr;59(4):1567–1568. doi: 10.1128/iai.59.4.1567-1568.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Parkkinen J., Korhonen T. K., Pere A., Hacker J., Soinila S. Binding sites in the rat brain for Escherichia coli S fimbriae associated with neonatal meningitis. J Clin Invest. 1988 Mar;81(3):860–865. doi: 10.1172/JCI113395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. SEARS H. J., BROWNLEE I. Further observations on the persistence of individual strains of Escherichia coli in the intestinal tract of man. J Bacteriol. 1952 Jan;63(1):47–57. doi: 10.1128/jb.63.1.47-57.1952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. SEARS H. J., BROWNLEE I., UCHIYAMA J. K. Persistence of individual strains of Escherichia coli in the intestinal tract of man. J Bacteriol. 1950 Feb;59(2):293–301. doi: 10.1128/jb.59.2.293-301.1950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. SEARS H. J., JANES H., SALOUM R., BROWNLEE I., LAMOREAUX L. F. Persistence of individual strains of Escherichia coli in man and dog under varying conditions. J Bacteriol. 1956 Mar;71(3):370–372. doi: 10.1128/jb.71.3.370-372.1956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sarff L. D., McCracken G. H., Schiffer M. S., Glode M. P., Robbins J. B., Orskov I., Orskov F. Epidemiology of Escherichia coli K1 in healthy and diseased newborns. Lancet. 1975 May 17;1(7916):1099–1104. doi: 10.1016/s0140-6736(75)92496-4. [DOI] [PubMed] [Google Scholar]
  19. Steffen E. K., Berg R. D., Deitch E. A. Comparison of translocation rates of various indigenous bacteria from the gastrointestinal tract to the mesenteric lymph node. J Infect Dis. 1988 May;157(5):1032–1038. doi: 10.1093/infdis/157.5.1032. [DOI] [PubMed] [Google Scholar]
  20. Tancrède C. Role of human microflora in health and disease. Eur J Clin Microbiol Infect Dis. 1992 Nov;11(11):1012–1015. doi: 10.1007/BF01967791. [DOI] [PubMed] [Google Scholar]
  21. Tullus K., Kühn I., Orskov I., Orskov F., Möllby R. The importance of P and type 1 fimbriae for the persistence of Escherichia coli in the human gut. Epidemiol Infect. 1992 Jun;108(3):415–421. doi: 10.1017/s095026880004992x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tullus K., Sjöberg P. Epidemiological aspects of P-fimbriated E. coli. II. Variations in incidence of E. coli infections in children attending a neonatal ward. Acta Paediatr Scand. 1986 Mar;75(2):205–210. doi: 10.1111/j.1651-2227.1986.tb10185.x. [DOI] [PubMed] [Google Scholar]
  23. Wadolkowski E. A., Laux D. C., Cohen P. S. Colonization of the streptomycin-treated mouse large intestine by a human fecal Escherichia coli strain: role of growth in mucus. Infect Immun. 1988 May;56(5):1030–1035. doi: 10.1128/iai.56.5.1030-1035.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Weiser M. M. Intestinal epithelial cell surface membrane glycoprotein synthesis. I. An indicator of cellular differentiation. J Biol Chem. 1973 Apr 10;248(7):2536–2541. [PubMed] [Google Scholar]
  25. Wold A. E., Caugant D. A., Lidin-Janson G., de Man P., Svanborg C. Resident colonic Escherichia coli strains frequently display uropathogenic characteristics. J Infect Dis. 1992 Jan;165(1):46–52. doi: 10.1093/infdis/165.1.46. [DOI] [PubMed] [Google Scholar]
  26. Wold A. E., Thorssén M., Hull S., Edén C. S. Attachment of Escherichia coli via mannose- or Gal alpha 1----4Gal beta-containing receptors to human colonic epithelial cells. Infect Immun. 1988 Oct;56(10):2531–2537. doi: 10.1128/iai.56.10.2531-2537.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wullenweber M., Beutin L., Zimmermann S., Jonas C. Influence of some bacterial and host factors on colonization and invasiveness of Escherichia coli K1 in neonatal rats. Infect Immun. 1993 May;61(5):2138–2144. doi: 10.1128/iai.61.5.2138-2144.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Zafriri D., Oron Y., Eisenstein B. I., Ofek I. Growth advantage and enhanced toxicity of Escherichia coli adherent to tissue culture cells due to restricted diffusion of products secreted by the cells. J Clin Invest. 1987 Apr;79(4):1210–1216. doi: 10.1172/JCI112939. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES